Healio

Zeposia exhibits ‘manageable’ cardiac safety profile in UC, multiple sclerosis

Please provide your email address to receive an email when new articles are posted on . Zeposia demonstrated a low incidence of treatment-related cardiac adverse events for patients with ulcerative ...
Labroots

Manufactured CBD Has Good Safety Profile, No Cardiac Issues

A pharmaceutically manufactured cannabidiol (CBD) formulation has a good overall safety profile with no cardiac safety concerns, reported a new study recently presented at Heart Failure 2025, a ...
The American Journal of Managed Care

Acalabrutinib Shows Low Cardiac Toxicity in Clinical, Real-World Data

Acalabrutinib demonstrates a favorable cardiovascular safety profile in CLL, with low cardiac failure rates compared to ibrutinib and chemoimmunotherapy. The selectivity of acalabrutinib reduces ...
ascopubs.org

Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin (PLD): Use of left ventricular ejection fraction (EF).

First-in-man trial of 4-(N-(S-penicillaminylacetyl)amino) phenylarsonous acid (PENAO) as a continuous intravenous infusion (CIVI), in patients (pt) with advanced solid tumours. This is an ASCO Meeting ...